{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:36:04Z","timestamp":1794612964057,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["no. 2007-0054931"],"award-info":[{"award-number":["no. 2007-0054931"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12974-016-0476-z","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T12:19:40Z","timestamp":1452946780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Minsook","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan-Suck","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Sik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Ram","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok-Sang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insop","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0299-3582","authenticated-orcid":false,"given":"Hyunsu","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,16]]},"reference":[{"issue":"Suppl 3","key":"476_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3233\/JAD-2010-100975","volume":"22","author":"VH Finder","year":"2010","unstructured":"Finder VH. Alzheimer's disease: a general introduction and pathomechanism. J Alzheimers Dis. 2010;22 Suppl 3:5\u201319.","journal-title":"J Alzheimers Dis"},{"key":"476_CR2","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1017\/S0317167100015547","volume":"39","author":"K Honjo","year":"2012","unstructured":"Honjo K, Black SE, Verhoeff NP. Alzheimer\u2019s disease, cerebrovascular disease, and the beta-amyloid cascade. Can J Neurol Sci. 2012;39:712\u201328.","journal-title":"Can J Neurol Sci"},{"key":"476_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13273-013-0009-0","volume":"9","author":"DKSJ Kim","year":"2013","unstructured":"Kim DKSJ, Park JD, Choi BS. Copper induces the accumulation of amyloid-beta in the brain. Mol Cell Toxicol. 2013;9:57\u201366.","journal-title":"Mol Cell Toxicol"},{"key":"476_CR4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nature02621","volume":"430","author":"MP Mattson","year":"2004","unstructured":"Mattson MP. Pathways towards and away from Alzheimer\u2019s disease. Nature. 2004;430:631\u20139.","journal-title":"Nature"},{"key":"476_CR5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nri1843","volume":"6","author":"HL Weiner","year":"2006","unstructured":"Weiner HL, Frenkel D. Immunology and immunotherapy of Alzheimer\u2019s disease. Nat Rev Immunol. 2006;6:404\u201316.","journal-title":"Nat Rev Immunol"},{"key":"476_CR6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0278-5846(03)00124-6","volume":"27","author":"EG McGeer","year":"2003","unstructured":"McGeer EG, McGeer PL. Inflammatory processes in Alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:741\u20139.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"476_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, et al. In-vivo measurement of activated microglia in dementia. Lancet. 2001;358:461\u20137.","journal-title":"Lancet"},{"key":"476_CR8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/01.wnl.0000338622.27876.0d","volume":"72","author":"A Okello","year":"2009","unstructured":"Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, et al. Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology. 2009;72:56\u201362.","journal-title":"Neurology"},{"key":"476_CR9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0197-0186(01)00040-7","volume":"39","author":"J Rogers","year":"2001","unstructured":"Rogers J, Lue LF. Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer\u2019s disease. Neurochem Int. 2001;39:333\u201340.","journal-title":"Neurochem Int"},{"key":"476_CR10","doi-asserted-by":"crossref","unstructured":"Cheng D, Spiro AS, Jenner AM, Garner B, Karl T. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer\u2019s disease transgenic mice. J Alzheimers Dis. 2014.","DOI":"10.3233\/JAD-140921"},{"key":"476_CR11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140:918\u201334.","journal-title":"Cell"},{"key":"476_CR12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/jpet.102.041616","volume":"306","author":"AV Terry Jr","year":"2003","unstructured":"Terry Jr AV, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer\u2019s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther. 2003;306:821\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"476_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt7","volume":"1","author":"SD Rountree","year":"2009","unstructured":"Rountree SD, Chan W, Pavlik VN, Darby EJ, Siddiqui S, Doody RS. Persistent treatment with cholinesterase inhibitors and\/or memantine slows clinical progression of Alzheimer disease. Alzheimers Res Ther. 2009;1:7.","journal-title":"Alzheimers Res Ther"},{"key":"476_CR14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.amjopharm.2009.06.003","volume":"7","author":"MN Sabbagh","year":"2009","unstructured":"Sabbagh MN. Drug development for Alzheimer\u2019s disease: where are we now and where are we headed? Am J Geriatr Pharmacother. 2009;7:167\u201385.","journal-title":"Am J Geriatr Pharmacother"},{"key":"476_CR15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron. 2003;39:409\u201321.","journal-title":"Neuron"},{"key":"476_CR16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neubiorev.2006.07.007","volume":"31","author":"L Gimenez-Llort","year":"2007","unstructured":"Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, Tobena A, et al. Modeling behavioral and neuronal symptoms of Alzheimer\u2019s disease in mice: a role for intraneuronal amyloid. Neurosci Biobehav Rev. 2007;31:125\u201347.","journal-title":"Neurosci Biobehav Rev"},{"key":"476_CR17","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1074\/jbc.M507892200","volume":"281","author":"S Oddo","year":"2006","unstructured":"Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, et al. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem. 2006;281:1599\u2013604.","journal-title":"J Biol Chem"},{"key":"476_CR18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1126\/science.177.4046.314","volume":"177","author":"E Habermann","year":"1972","unstructured":"Habermann E. Bee and wasp venoms. Science. 1972;177:314\u201322.","journal-title":"Science"},{"key":"476_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.chemphyslip.2006.12.006","volume":"146","author":"L Linderoth","year":"2007","unstructured":"Linderoth L, Peters GH, Jorgensen K, Madsen R, Andresen TL. Synthesis of sn-1 functionalized phospholipids as substrates for secretory phospholipase A2. Chem Phys Lipids. 2007;146:54\u201366.","journal-title":"Chem Phys Lipids"},{"key":"476_CR20","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1016\/S0021-9258(17)36794-7","volume":"269","author":"EA Dennis","year":"1994","unstructured":"Dennis EA. Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem. 1994;269:13057\u201360.","journal-title":"J Biol Chem"},{"key":"476_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-2952(94)90216-X","volume":"48","author":"AB Mukherjee","year":"1994","unstructured":"Mukherjee AB, Miele L, Pattabiraman N. Phospholipase A2 enzymes: regulation and physiological role. Biochem Pharmacol. 1994;48:1\u201310.","journal-title":"Biochem Pharmacol"},{"key":"476_CR22","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fasebj.5.7.1901288","volume":"5","author":"EA Dennis","year":"1991","unstructured":"Dennis EA, Rhee SG, Billah MM, Hannun YA. Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J. 1991;5:2068\u201377.","journal-title":"FASEB J"},{"key":"476_CR23","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/eji.200535567","volume":"36","author":"F Granata","year":"2006","unstructured":"Granata F, Frattini A, Loffredo S, Del Prete A, Sozzani S, Marone G, et al. Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A2 in human lung macrophages. Eur J Immunol. 2006;36:1938\u201350.","journal-title":"Eur J Immunol"},{"key":"476_CR24","volume":"9","author":"H Kim","year":"2014","unstructured":"Kim H, Keum DJ, Kwak J, Chung HS, Bae H. Bee venom phospholipase A2 protects against acetaminophen-induced acute liver injury by modulating regulatory T cells and IL-10 in mice. PLoS One. 2014;9:e114726.","journal-title":"PLoS One"},{"key":"476_CR25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11:47\u201360.","journal-title":"J Neurosci Methods"},{"key":"476_CR26","doi-asserted-by":"crossref","first-page":"150153","DOI":"10.1155\/2014\/150153","volume":"2014","author":"M Ye","year":"2014","unstructured":"Ye M, Lee SG, Chung ES, Lim SJ, Kim WS, Yoon H, et al. Neuroprotective effects of cuscutae semen in a mouse model of Parkinson's disease. Evid Based Complement Alternat Med. 2014;2014:150153.","journal-title":"Evid Based Complement Alternat Med"},{"key":"476_CR27","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1523\/JNEUROSCI.20-10-03529.2000","volume":"20","author":"C Sala","year":"2000","unstructured":"Sala C, Rudolph-Correia S, Sheng M. Developmentally regulated NMDA receptor-dependent dephosphorylation of cAMP response element-binding protein (CREB) in hippocampal neurons. J Neurosci. 2000;20:3529\u201336.","journal-title":"J Neurosci"},{"key":"476_CR28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-0270(85)90026-3","volume":"13","author":"G Paxinos","year":"1985","unstructured":"Paxinos G, Watson C, Pennisi M, Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods. 1985;13:139\u201343.","journal-title":"J Neurosci Methods"},{"key":"476_CR29","first-page":"999","volume":"47","author":"BJ Fueger","year":"2006","unstructured":"Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, et al. Impact of animal handling on the results of 18F-FDG PET studies in mice. J Nucl Med. 2006;47:999\u20131006.","journal-title":"J Nucl Med"},{"key":"476_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2967\/jnumed.108.056374","volume":"50","author":"Q Bao","year":"2009","unstructured":"Bao Q, Newport D, Chen M, Stout DB, Chatziioannou AF. Performance evaluation of the inveon dedicated PET preclinical tomograph based on the NEMA NU-4 standards. J Nucl Med. 2009;50:401\u20138.","journal-title":"J Nucl Med"},{"key":"476_CR31","first-page":"589","volume":"2","author":"HS Swartzwelder","year":"1981","unstructured":"Swartzwelder HS, Dyer RS, Holahan W, Myers RD. Activity changes in rats following acute trimethyltin exposure. Neurotoxicology. 1981;2:589\u201393.","journal-title":"Neurotoxicology"},{"key":"476_CR32","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/eji.200939613","volume":"40","author":"YY Setiady","year":"2010","unstructured":"Setiady YY, Coccia JA, Park PU. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes. Eur J Immunol. 2010;40:780\u2013786.","journal-title":"Eur J Immunol"},{"key":"476_CR33","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.4049\/jimmunol.1001373","volume":"185","author":"H Lee","year":"2010","unstructured":"Lee H, Kwon Y, Lee JH, Kim J, Shin MK, Kim SH, Bae H: Methyl gallate exhibits potent antitumor activities by inhibiting tumor infiltration of CD4+CD25+ regulatory T cells. J Immunol. 2010;185:6698\u2013705.","journal-title":"J Immunol"},{"key":"476_CR34","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1586\/ern.11.155","volume":"11","author":"S Karantzoulis","year":"2011","unstructured":"Karantzoulis S, Galvin JE. Distinguishing Alzheimer\u2019s disease from other major forms of dementia. Expert Rev Neurother. 2011;11:1579\u201391.","journal-title":"Expert Rev Neurother"},{"key":"476_CR35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.neurobiolaging.2014.09.019","volume":"36","author":"AC Schmole","year":"2015","unstructured":"Schmole AC, Lundt R, Ternes S, Albayram O, Ulas T, Schultze JL, et al. Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer\u2019s disease mouse model. Neurobiol Aging. 2015;36:710\u20139.","journal-title":"Neurobiol Aging"},{"key":"476_CR36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fphar.2012.00014","volume":"3","author":"E Solito","year":"2012","unstructured":"Solito E, Sastre M. Microglia function in Alzheimer\u2019s disease. Front Pharmacol. 2012;3:14.","journal-title":"Front Pharmacol"},{"key":"476_CR37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF03033818","volume":"8","author":"I Kadiu","year":"2005","unstructured":"Kadiu I, Glanzer JG, Kipnis J, Gendelman HE, Thomas MP. Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases. Neurotox Res. 2005;8:25\u201350.","journal-title":"Neurotox Res"},{"key":"476_CR38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"PL McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995;21:195\u2013218.","journal-title":"Brain Res Brain Res Rev"},{"key":"476_CR39","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1172\/JCI200423395","volume":"114","author":"Z Fehervari","year":"2004","unstructured":"Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest. 2004;114:1209\u201317.","journal-title":"J Clin Invest"},{"key":"476_CR40","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/intimm\/12.8.1145","volume":"12","author":"Y Kuniyasu","year":"2000","unstructured":"Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol. 2000;12:1145\u201355.","journal-title":"Int Immunol"},{"key":"476_CR41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0895-3988(10)60072-4","volume":"23","author":"L Wang","year":"2010","unstructured":"Wang L, Xie Y, Zhu LJ, Chang TT, Mao YQ, Li J. An association between immunosenescence and CD4(+)CD25(+) regulatory T cells: a systematic review. Biomed Environ Sci. 2010;23:327\u201332.","journal-title":"Biomed Environ Sci"},{"key":"476_CR42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","volume":"76","author":"ML Block","year":"2005","unstructured":"Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76:77\u201398.","journal-title":"Prog Neurobiol"},{"key":"476_CR43","doi-asserted-by":"crossref","first-page":"7254","DOI":"10.4049\/jimmunol.181.10.7254","volume":"181","author":"M Jana","year":"2008","unstructured":"Jana M, Palencia CA, Pahan K. Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer\u2019s disease. J Immunol. 2008;181:7254\u201362.","journal-title":"J Immunol"},{"key":"476_CR44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1515\/CCLM.2001.048","volume":"39","author":"F Muehlhauser","year":"2001","unstructured":"Muehlhauser F, Liebl U, Kuehl S, Walter S, Bertsch T, Fassbender K. Aggregation-dependent interaction of the Alzheimer\u2019s beta-amyloid and microglia. Clin Chem Lab Med. 2001;39:313\u20136.","journal-title":"Clin Chem Lab Med"},{"key":"476_CR45","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1179\/016164106X98107","volume":"28","author":"S Delgado","year":"2006","unstructured":"Delgado S, Sheremata WA. The role of CD4+ T-cells in the development of MS. Neurol Res. 2006;28:245\u20139.","journal-title":"Neurol Res"},{"key":"476_CR46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/NMM:7:3:255","volume":"7","author":"T Town","year":"2005","unstructured":"Town T, Tan J, Flavell RA, Mullan M. T-cells in Alzheimer\u2019s disease. Neuromolecular Med. 2005;7:255\u201364.","journal-title":"Neuromolecular Med"},{"key":"476_CR47","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531\u201362.","journal-title":"Annu Rev Immunol"},{"key":"476_CR48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"476_CR49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nm.1927","volume":"15","author":"A Liesz","year":"2009","unstructured":"Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med. 2009;15:192\u20139.","journal-title":"Nat Med"},{"key":"476_CR50","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","volume":"82","author":"AD Reynolds","year":"2007","unstructured":"Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL. Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson\u2019s disease. J Leukoc Biol. 2007;82:1083\u201394.","journal-title":"J Leukoc Biol"},{"key":"476_CR51","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3233\/JAD-2010-100852","volume":"22","author":"S Subramanian","year":"2010","unstructured":"Subramanian S, Ayala P, Wadsworth TL, Harris CJ, Vandenbark AA, Quinn JF, Offner H. CCR6: a biomarker for Alzheimer\u2019s-like disease in a triple transgenic mouse model. J Alzheimers Dis. 2010;22:619\u201329.","journal-title":"J Alzheimers Dis"},{"key":"476_CR52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2009-1015","volume":"17","author":"A Larbi","year":"2009","unstructured":"Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, et al. Dramatic shifts in circulating CD4 but not CD8 T cell subsets in mild Alzheimer\u2019s disease. J Alzheimers Dis. 2009;17:91\u2013103.","journal-title":"J Alzheimers Dis"},{"key":"476_CR53","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/ki.2015.147","volume":"88","author":"H Kim","year":"2015","unstructured":"Kim H, Lee H, Lee G, Jang H, Kim SS, Yoon H, et al. Phospholipase A2 inhibits cisplatin-induced acute kidney injury by modulating regulatory T cells by the CD206 mannose receptor. Kidney Int. 2015;88:550\u20139.","journal-title":"Kidney Int"},{"key":"476_CR54","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI63891","volume":"123","author":"R Klingenberg","year":"2013","unstructured":"Klingenberg R, Gerdes N, Badeau RM, Gistera A, Strodthoff D, Ketelhuth DF, et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J Clin Invest. 2013;123:1323\u201334.","journal-title":"J Clin Invest"},{"key":"476_CR55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.20061852","volume":"204","author":"K Lahl","year":"2007","unstructured":"Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, Eberl G, et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med. 2007;204:57\u201363.","journal-title":"J Exp Med"},{"key":"476_CR56","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/eji.1830260730","volume":"26","author":"O Taguchi","year":"1996","unstructured":"Taguchi O, Takahashi T. Administration of anti-interleukin-2 receptor alpha antibody in vivo induces localized autoimmune disease. Eur J Immunol. 1996;26:1608\u201312.","journal-title":"Eur J Immunol"},{"key":"476_CR57","doi-asserted-by":"crossref","first-page":"5979","DOI":"10.4049\/jimmunol.168.12.5979","volume":"168","author":"RS McHugh","year":"2002","unstructured":"McHugh RS, Shevach EM. Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol. 2002;168:5979\u201383.","journal-title":"J Immunol"},{"key":"476_CR58","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1016\/j.ajpath.2014.07.004","volume":"184","author":"TM Weitz","year":"2014","unstructured":"Weitz TM, Gate D, Rezai-Zadeh K, Town T. MyD88 is dispensable for cerebral amyloidosis and neuroinflammation in APP\/PS1 transgenic mice. Am J Pathol. 2014;184:2855\u201361.","journal-title":"Am J Pathol"},{"key":"476_CR59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1742-2094-10-150","volume":"10","author":"F Goni","year":"2013","unstructured":"Goni F, Herline K, Peyser D, Wong K, Ji Y, Sun Y, et al. Immunomodulation targeting of both Abeta and tau pathological conformers ameliorates Alzheimer\u2019s disease pathology in TgSwDI and 3xTg mouse models. J Neuroinflammation. 2013;10:150.","journal-title":"J Neuroinflammation"},{"key":"476_CR60","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","volume":"24","author":"S Oddo","year":"2003","unstructured":"Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM. Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer\u2019s disease. Neurobiol Aging. 2003;24:1063\u201370.","journal-title":"Neurobiol Aging"},{"key":"476_CR61","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM. Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice. Neuron. 2005;45:675\u201388.","journal-title":"Neuron"},{"key":"476_CR62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12017-009-8109-7","volume":"12","author":"RA Sperling","year":"2010","unstructured":"Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, et al. Functional alterations in memory networks in early Alzheimer\u2019s disease. Neuromolecular Med. 2010;12:27\u201343.","journal-title":"Neuromolecular Med"},{"key":"476_CR63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuroimage.2007.06.032","volume":"38","author":"MM Mirrione","year":"2007","unstructured":"Mirrione MM, Schiffer WK, Fowler JS, Alexoff DL, Dewey SL, Tsirka SE. A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator. Neuroimage. 2007;38:34\u201342.","journal-title":"Neuroimage"},{"key":"476_CR64","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/syn.20216","volume":"59","author":"MM Mirrione","year":"2006","unstructured":"Mirrione MM, Schiffer WK, Siddiq M, Dewey SL, Tsirka SE. PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy. Synapse. 2006;59:119\u201321.","journal-title":"Synapse"},{"key":"476_CR65","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2165\/00002018-199819060-00004","volume":"19","author":"A Nordberg","year":"1998","unstructured":"Nordberg A, Svensson AL. Cholinesterase inhibitors in the treatment of Alzheimer\u2019s disease: a comparison of tolerability and pharmacology. Drug Saf. 1998;19:465\u201380.","journal-title":"Drug Saf"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0476-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:34:22Z","timestamp":1748738062000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jneuroinflammation.com\/content\/13\/1\/10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,16]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1186\/s12974-016-0476-z","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,16]]},"article-number":"10"}}